Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
02/14/2017 02/15/2017 02/16/2017 02/17/2017 02/20/2017 Date
100.25(c) 100.25(c) 101.5(c) 101.35(c) 101.5(c) Last
306 278 429 277 600 083 539 307 241 084 Volume
-0.74% 0.00% +1.25% -0.15% +0.15% Change
More quotes
Financials (€)
Sales 2016 15 062 M
EBIT 2016 3 447 M
Net income 2016 1 789 M
Debt 2016 11 025 M
Yield 2016 1,21%
Sales 2017 15 569 M
EBIT 2017 3 405 M
Net income 2017 1 876 M
Debt 2017 9 065 M
Yield 2017 1,30%
P/E ratio 2016 23,96
P/E ratio 2017 22,83
EV / Sales2016 1,60x
EV / Sales2017 1,42x
Capitalization 13 099 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.It operates through the following segments: Healthcare, Life Science, and Performance Materials.The Healthcare segment comprises of the businesses that were reported separately as the Merck Serono and Consumer Health... 
Sector
Pharmaceuticals
Calendar
03/09Earnings Release
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
02/16 MERCK : New Hypertension Findings from Merck KGaA Described [Management of Hyper..
02/16 MERCK : North American Businesses of Merck KGaA, Darmstadt, Germany Certified as..
02/15 MERCK : to Supply Single-Use Systems to WuXi Biologics for Non-GMP Pilot Plant i..
02/09 Verastem Announces Dosing of First Patient in Combination Trial of Defactinib..
02/09 MERCK : North American Businesses of Merck KGaA, Darmstadt, Germany Certified as..
02/09 MERCK : Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with ..
02/07 MERCK : Jaffrey biochemical company to pay fine by EPA after alleged water pollu..
02/07 MERCK : Millipore settles lawsuit with EPA
02/07 MERCK : Jaffrey firm to pay penalty and comply with Clean Water Act
02/06 MERCK : Jaffrey, N.H. Facility to Upgrade Its Wastewater Treatment Systems Under..
More news
Sector news : Specialty & Advanced Pharmaceuticals
03:32a Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
02/20DJBAYER : Trump Backing for Bayer's Monsanto Deal Buoys Investors
02/20DJBAYER : 4Q 2016 -- Forecast
02/20DJASTRAZENECA : licenses Cancer Drug Zoladex to TerSera for the US, Canada
02/17DJSHIRE : Files 8K - Other Events
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2016Towards the breakout of a major resistance level
2014Prices move higher as positive news are released
More Strategies
Latest Tweets
02/20Execution is the challenge in India: Merck KGaA’s Udit Batra  
02/20Merck KGaA given €118.00 PT by Deutsche Bank AG. buy rating.  
02/20Osborn Williams & Donohoe LLC Cuts Position in Merck & Company, Inc. .. 
02/19Merck, Bristol-Myers, Incyte Race For A Cure In $25 Billion Immuno-Oncology M..
3
02/18After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?
1
More tweets
Qtime:110
News from SeekingAlpha
02/03 Pfizer May Be Another IBM
01/23 Merck KGaA teams up with Domain Therapeutics in immuno-oncology
01/18 Astra's Mystic Mystery And Other Surprises In Store
01/12 Vertex And German Merck Find Their Perfect Fit
01/12 JPMorgan Day Three Roundup - Trump Reminds The Sector Who's In Charge
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 109 €
Spread / Average Target 7,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA2.22%13 901
ABBVIE INC-1.36%100 382
KYOWA HAKKO KIRIN CO L..1.30%8 381
JAZZ PHARMACEUTICALS P..25.83%8 217
MALLINCKRODT PLC9.88%5 731
ZHANGZHOU PIENTZEHUANG..-1.40%3 969
More Results